540788 — Aspira Pathlab & Diagnostics Balance Sheet
0.000.00%
- IN₹1.35bn
- IN₹1.37bn
- IN₹249.82m
Annual balance sheet for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 16.4 | 23.5 | 13.8 | 21.4 | 16.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 50 | 29.5 | 24.1 | 25.6 | 20 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 71.4 | 58.6 | 43.6 | 53.6 | 45.9 |
| Net Property, Plant And Equipment | 68.2 | 53.1 | 41.2 | 38.6 | 38.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 181 | 173 | 147 | 175 | 185 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.9 | 15.8 | 20.7 | 23.7 | 32 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 53.5 | 45.9 | 45.7 | 53 | 62.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 128 | 128 | 101 | 122 | 122 |
| Total Liabilities & Shareholders' Equity | 181 | 173 | 147 | 175 | 185 |
| Total Common Shares Outstanding |